For the first time, objective evidence that your symptoms
are real and there is help.
In 5 out
of 5 patients observed on and off Prelief:
- There were marked reductions in patients' reported symptoms (pain,
urgency) when taking Prelief, with these reports being matched by
a large drop in a laboratory-readable urinary marker indicative of
cellular distress.
- When the patients discontinued use of Prelief, there was a rise
in both reported symptoms as well as in the urinary cellular distress
marker. When Prelief was regiven, both markers again dropped.(1)
A full clinical study is underway to confirm the above observations
in a larger, controlled group.
Prelief and
Interstitial Cystitis
In two separate clinical surveys of over 200 women each (2,3),
Prelief delivered a large reduction in the pain, urgency and discomfort
that are normally associated with acidic foods, with the benefits showing
up to a 70% reduction in pain and 61% reduction in urgency.
Many male
patients diagnosed with non-bacterial prostatitis/chronic pelvic pain
syndrome may actually have interstitial cystitis (IC). (4,5)
Prelief
and Overactive Bladder
A study of patients with overactive bladder confirms that use of Prelief
results in significant improvements in:
- Ability
to socialize and interact with friends
- Quality
and/or quantity of sleep
- Ability
to go places as wanted
- Ability
to attend entertainment activities
>
- Quality
of life (6)
REFERENCES
1
DiTrolio, NY Section AUA, Using NMP22® as a Quantitative Evaluation
in the Treatment of Interstitial Cystitis, Athens, Greece, October 2003
2 Lukban, Gomelsky, et al, Urology 57-6A, 119-120,
June 2001 (Abstract)
3 Tu, Polansky, et al, Quebec Urological Association,
www.auq.org/1998/4.html, 1998 (Abstract)
4 Interstitial Cystitis and Chronic Prostatitis:
the Same Syndrome?; Sant, G.R. and Nickel, J.C., Textbook of Prostatits,
Isis Medical Media Limited, 1999
5 Prostatitis: What's New?; Antolak, S.J., Jr.,
Mayo Clinic Continuing Medical Education Syllabus, October 2002
6 Kennelly and Clark, 67th Annual Meeting SE
Section Am. Urol. Assn., March 2003